Cargando…
Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation
BACKGROUNDS AND AIMS: It is well known that angiogenesis contributes to the progression of chronic obstructive pulmonary disease (COPD) by initiating the remodeling of bronchial vasculature. However, the specific molecular mechanisms are incompletely understood. This research aimed to explore whethe...
Autores principales: | Wu, Yanqiu, Qin, Jiangyue, He, Junyun, Shen, Yongchun, Wang, Hao, Li, Yanping, Zeng, Qianglin, Dong, Jiajia, An, Yunfei, Xiong, Shuguang, Feng, Mei, Wen, Fuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049271/ https://www.ncbi.nlm.nih.gov/pubmed/32158205 http://dx.doi.org/10.2147/COPD.S234760 |
Ejemplares similares
-
Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD
por: Li, Diandian, et al.
Publicado: (2019) -
Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients
por: Wu, Yanqiu, et al.
Publicado: (2015) -
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018) -
Increased Serum ox-LDL Levels Correlated with Lung Function, Inflammation, and Oxidative Stress in COPD
por: Shen, Yongchun, et al.
Publicado: (2013) -
The association of elevated circulating endocan levels with lung function decline in COPD patients
por: Dai, Luqi, et al.
Publicado: (2018)